参附注射液联合血必净注射液对ICU脓毒性休克患者中医证候积分、血清炎症因子水平及血流动力学指标的影响
江其影,陈矛,薛秋平,蔡婷婷,刘光天,冯彩霞
摘要(Abstract):
目的观察参附注射液联合血必净注射治疗对ICU脓毒性休克患者中医证候积分、血清炎症因子水平及血流动力学指标的影响并探讨其作用机制。方法将74例患者随机分为两组,对照组予常规治疗,观察组在此基础上增加参附注射液联合血必净注射治疗。比较两组患者治疗效果及治疗前后中医证候积分、血清炎症因子水平及血流动力学指标。结果治疗后两组急性生理与慢性健康(APACHEⅡ)评分、中医证候积分均低于治疗前(P<0.05),且观察组显著低于对照组(P<0.05);治疗后两组患者血清超敏C反应蛋白(hsCRP)、白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)水平均低于治疗前(P<0.05),且观察组显著低于对照组(P<0.05);治疗后两组患者平均动脉压(MAP)、中心静脉压(CVP)、外周血管阻力(SVR)均高于治疗前(P<0.05),且观察组显著高于对照组(P<0.05);治疗后两组患者心率(HR)、平均肺动脉压(MPAP)、肺动脉楔压(PAWP)、一氧化碳(CO)、肺血管阻力(PVR)、血乳酸(Lac)均低于治疗前(P<0.05),且观察组显著低于对照组(P<0.05)。结论参附注射液联合血必净注射液治疗ICU脓毒性休克的临床疗效更显著,并能有效改善患者中医症候积分、血清炎症因子水平及血液动力学指标,安全有效。
关键词(KeyWords): 脓毒性休克;参附;血必净;中医证候积分;血清炎症因子;血流动力学
基金项目(Foundation):
作者(Author): 江其影,陈矛,薛秋平,蔡婷婷,刘光天,冯彩霞
参考文献(References):
- [1]单洁龄.血必净注射液联合乌司他丁对脓毒性休克患者心肌损伤保护效应的研究[J].现代中西医结合杂志,2016,25(11):1166-1168.
- [2]Valparaiso AP,Vicente DA,Bograd BA,et al.Modeling acute traumatic injury[J].Journal of Surgical Research,2015,194(1):220-232.
- [3]周仙仕,唐光华,李俊,等.血必净降低脓毒性休克患者病死率的系统评价[J].中华中医药学刊,2016,34(9):2161-2164.
- [4]Mouncey PR,Osborn TM,Power GS,et al.Trial of early,goal-directed resuscitation for septic shock[J].NEJM,2015,372(14):1301-1311.
- [5]Annane D,Bellissant E,Sebille V,et al.Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve[J].British Journal of Clinical Pharmacology,2015,46(6):589-597.
- [6]邵洁,李雯,史惠强.血必净注射液辅助治疗老年脓毒性休克疗效观察[J].人民军医,2012,34(2):144-146.
- [7]明自强,俞林明,吕银祥.血必净注射液对脓毒性休克患者氧利用率、中心静脉血氧饱和度及乳酸影响的临床研究[J].中华中医药学刊,2012,19(1):176-179.
- [8]姚咏明.深化对血必净注射液治疗脓毒症新机制的认识[J].中国中西医结合急救杂志,2013,20(4):193-194.
- [9]Shen H,Xu Y,Qin H,et al.Effect of Xuebijin injection on Pselectin of pulmonary vascular endothelial cells in rats with pulmonary thromboembolism[J].ZWZBJJYX,2014,26(12):923-925.
- [10]李国政,肖扬,朱家旺,等.血必净注射液治疗脓毒性休克的系统评价[J].中国中医急症,2016,25(5):834-838.
- [11]Angus DC,Barnato AE,Bell D,et al.A systematic review and meta-analysis of early goal-directed therapy for septic shock:the ARISE,Pro CESS and Pro MISe Investigators[J].Intensive Care Medicine,2015,41(9):1549-1560.
- [12]Schlapbach LJ,Straney L,Alexander J,et al.Mortality related to invasive infections,sepsis,and septic shock in critically ill children in Australia and New Zealand,2002-13:a multicentre retrospective cohort study[J].Lancet Infectious Diseases,2015,15(1):46-54.
- [13]何健卓,谭展鹏,张敏州,等.血必净注射液对严重脓毒症患者血流动力学及内皮功能影响的前瞻性研究[J].中华危重病急救医学,2015,27(2):127-132.
- [14]Leone M,Asfar P,Radermacher P,et al.Optimizing mean arterial pressure in septic shock:a critical reappraisal of the literature[J].Critical Care,2015,19(1):101.
- [15]Gupta RG,Hartigan SM,Kashiouris MG,et al.Early goal-directed resuscitation of patients with septic shock:current evidence and future directions[J].Critical Care,2015,19(1):286.
- [16]唐晋,陈雪梅,彭超华,等.血必净注射液联合持续血液净化治疗重症脓毒症的效果及对血清IL-6、TNF-α的影响[J].现代生物医学进展,2015,15(17):3283-3285.
- [17]汪勤,朱羿,陈文麒,等.芒硝外敷和新斯的明足三里穴注射联合血必净治疗严重脓毒症的临床疗效观察[J].中国中西医结合急救杂志,2016,23(5):464-468.
- [18]田苗,李阿囡,李青.血必净联合激素在脓毒血症的急诊处理方面的疗效分析[J].中国医药导刊,2015,17(7):718-719.
- [19]Geer LD,Engvall J,Oscarsson A.Strain echocardiography in septic shock-a comparison with systolic and diastolic function parameters,cardiac biomarkers and outcome[J].Critical Care,2015,19(1):1-9.
- [20]丁国娟,吕铁.血必净注射液联合参附注射液治疗脓毒症效果探讨[J].中国全科医学,2015,23(11):1300-1303.